---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-091438"
form_type: "8-K"
ticker: "AIDX"
cik: "0001139685"
company_name: "20/20 Biolabs, Inc."
filed_at: "2026-08-19T13:19:15+00:00"
generated_at: "2026-08-19T13:20:20.244348+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# 20/20 Biolabs annual meeting: directors elected, auditor ratified, charter amendment fails, adjourned to Sept 16

## Summary
- Six directors elected: Jonathan Cohen, John G. Compton, Richard M. Cohen, Prasanth Reddy, John W. Rollins, Michael A. Ross; each received >2.6M votes for.
- Ratified dbbmckennon as independent auditor for FY2026: 4,105,584 for, 132,421 against, 18,832 abstentions.
- Approved 2026 Equity Incentive Plan: 2,183,335 for, 573,931 against, 1,433,721 broker non-votes.
- Proposal 3 (Charter Amendment) failed to get sufficient votes; meeting adjourned to Sept 16, 2026 at 10:00 a.m. ET to solicit more proxies.
- Quorum: 4,256,837 shares represented out of 12,251,198 outstanding.

## SEC filing metadata
- accession: 0001213900-26-091438
- form_type: 8-K
- ticker: AIDX
- cik: 0001139685
- company_name: 20/20 Biolabs, Inc.
- filed_at: 2026-08-19T13:19:15+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1139685/000121390026091438/0001213900-26-091438-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1139685/000121390026091438/ea0302628-8k_2020bio.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-091438
- JSON: https://secwatch.observer/filing/0001213900-26-091438.json
- Plain text: https://secwatch.observer/filing/0001213900-26-091438.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.